Inside STAT: An experimental peanut allergy treatment is effective, but not always easy to take

A new review of the evidence on an experimental peanut allergy treatment shows it's effective — but can be difficult to tolerate. The treatment, developed by Aimmune Therapeutics, is a capsule filled with a precise amount of peanut flour that gets mixed into food. The idea: Desensitize people to peanut proteins over time. The company enrolled 500 young patients with allergies so severe they couldn't consume more than half a peanut. After a year, more than two-thirds of patients on the treatment could consume four peanuts, compared to 4 percent on the placebo. But some of the patients on the therapy had to use epinephrine to counteract mild to moderate allergic reactions, and one patient experienced anaphylaxis. STAT's Adam Feuerstein has more here.